| Lactate beyond a waste metabolite: metabolic affairs and signaling in malignancy F Baltazar, J Afonso, M Costa, S Granja Frontiers in Oncology 10, 520394, 2020 | 123 | 2020 |
| Competitive glucose metabolism as a target to boost bladder cancer immunotherapy J Afonso, LL Santos, A Longatto-Filho, F Baltazar Nature Reviews Urology 17 (2), 77-106, 2020 | 105 | 2020 |
| CD147 and MCT1‐potential partners in bladder cancer aggressiveness and cisplatin resistance J Afonso, LL Santos, V Miranda‐Gonçalves, A Morais, T Amaro, ... Molecular carcinogenesis 54 (11), 1451-1466, 2015 | 86 | 2015 |
| Lactate and lactate transporters as key players in the maintenance of the Warburg effect A Pereira-Nunes, J Afonso, S Granja, F Baltazar Tumor microenvironment: the main driver of metabolic adaptation, 51-74, 2020 | 46 | 2020 |
| The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion–the prognostic contribution of related molecular markers J Afonso, LL Santos, T Amaro, F Lobo, A Longatto‐Filho Histopathology 55 (5), 514-524, 2009 | 45 | 2009 |
| Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma–MCT1 as potential target in diffuse large B cell lymphoma J Afonso, T Pinto, S Simões-Sousa, F Schmitt, A Longatto-Filho, ... Cellular oncology 42, 303-318, 2019 | 41 | 2019 |
| Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness J Afonso, LL Santos, A Morais, T Amaro, A Longatto-Filho, F Baltazar Cell Cycle 15 (3), 368-380, 2016 | 38 | 2016 |
| In vivo anticancer activity of AZD3965: a systematic review A Silva, B Antunes, A Batista, F Pinto-Ribeiro, F Baltazar, J Afonso Molecules 27 (1), 181, 2021 | 37 | 2021 |
| CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis J Afonso, A Longatto-Filho, F Baltazar, N Sousa, FE Costa, A Morais, ... European Journal of Surgical Oncology (EJSO) 37 (9), 811-817, 2011 | 37 | 2011 |
| Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics? M Singh, J Afonso, D Sharma, R Gupta, V Kumar, R Rani, F Baltazar, ... Seminars in Cancer Biology 90, 1-14, 2023 | 30 | 2023 |
| Low RKIP expression associates with poor prognosis in bladder cancer patients J Afonso, A Longatto-Filho, O Martinho, F Lobo, T Amaro, RM Reis, ... Virchows Archiv 462, 445-453, 2013 | 26 | 2013 |
| The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN PA Oliveira, R Arantes-Rodrigues, C Sousa-Diniz, A Colaço, L Lourenco, ... Anticancer research 29 (8), 3221-3226, 2009 | 25 | 2009 |
| Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours AT Torres de Oliveira, RM Reis, J Alfonso, O Martinho, D Matos, ... Histology and histopathology, Vol. 26, nº12 (2011), 2011 | 18 | 2011 |
| Phospho-mTOR in non-tumour and tumour bladder urothelium: pattern of expression and impact on urothelial bladder cancer patients J Afonso, A Longatto-Filho, VM Da Silva, T Amaro, LL Santos Oncology Letters 8 (4), 1447-1454, 2014 | 13 | 2014 |
| Prognostic value of monocarboxylate transporter 1 overexpression in cancer: a systematic review A Silva, MC Cerqueira, B Rosa, C Sobral, F Pinto-Ribeiro, MF Costa, ... International Journal of Molecular Sciences 24 (6), 5141, 2023 | 11 | 2023 |
| Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy J Afonso, C Gonçalves, M Costa, D Ferreira, L Santos, A Longatto-Filho, ... Cancers 15 (3), 982, 2023 | 10 | 2023 |
| Is DNA content alteration a consequence of proliferative and differentiation changes in urothelial bladder tumors L Santos, C Lameiras, J Afonso, C Palmeira, S Pereira, C Costa, T Amaro, ... Acta Urol 20, 9-17, 2003 | 9 | 2003 |
| Targeting metabolic reprogramming as an anti-cancer strategy: aiming at monocarboxylate transporters C Pinheiro, F Morais-Santos, S Granja, V Miranda-Goncalves, J Afonso, ... Frontiers in anti-cancer drug discovery. Bentham Science Publishers, Sharjah …, 2015 | 8 | 2015 |
| Urothelial bladder cancer progression: lessons learned from the bench JP Afonso, R Freitas, F Lobo, A Morais, J Oliveira, T Amaro, R Reis, ... J Cancer Metastasis Treat 1 (2), 57-66, 2015 | 6 | 2015 |
| Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study S Gholami, C Chamorro-Petronacci, M Pérez-Sayáns, ... Journal of Applied Oral Science 31, e20220461, 2023 | 3 | 2023 |
